Newsroom
LVIS Corporation Signs MOU with Daegu Health College to Foster Next-Generation NeuroMatch Technicians
Palo Alto, CA – November 22, 2024 – LVIS Corporation, an innovator in neural information analysis technology, has signed a Memorandum of Understanding (MOU) with Daegu Health College in South Korea to establish a collaboration for training skilled technicians in the use of NeuroMatch®, LVIS’s cutting-edge AI-driven brain diagnostic technology. This partnership aims to educate ... Read more
LVIS Corporation Launches NeuroMatch® Access: Cloud-Based Platform Revolutionizing EEG Diagnostics
Palo Alto, CA – October 1, 2024– LVIS Corporation, an innovator in neural information analysis technology, has launched NeuroMatch® Access, a cloud-based SaaS platform designed to revolutionize EEG diagnostics by streamlining review and enhancing physician collaboration. This groundbreaking platform, now available to the U.S. market, helps improve clinical workflows allowing neurologists to quickly review and ... Read more
NeuroMatch by LVIS Wins 2024 IMPACT Award for Diagnostic Software of the Year
We are thrilled to announce that NeuroMatch®, LVIS’s revolutionary EEG diagnostic platform, has been recognized with the prestigious 2024 IMPACT Award for Diagnostic Software of the Year. Presented by the Internet Marketing Association (IMA) at their IMPACT5050 conference held at the One & Only Mandarina resort in Mexico, this award highlights NeuroMatch’s significant contribution to ... Read more
Exploring the LVIS NeuroMatch Center in South Korea: Revolutionizing Brain Health and Neuroscience
In June 2024, the world’s first LVIS NeuroMatch Center opened in Daegu, South Korea. This innovative facility is the first educational facility in the world where individuals can experience the groundbreaking NeuroMatch® platform firsthand. As a pivotal development in neuroscience, the NeuroMatch platform is cutting-edge AI-based Software as a Medical Device (SaMD) designed to revolutionize ... Read more
Advancing Brain Health: Insights from the NeuroForum on Epilepsy, Sleep Disorders, and the NeuroMatch Platform
Neurological health is the top cause of disability worldwide, but LVIS Corp is committed to revolutionizing diagnosis and treatment through cutting-edge neural information analysis technology. On June 28, 2024, our company’s recent NeuroForum served as an enlightening platform aimed at educating the public on epilepsy and sleep disorders—two critical areas of brain health that significantly ... Read more
LVIS NeuroMatch® Software Successfully Launched in 10 South Korean Hospitals
Over the years, researchers have made significant leaps in how we identify, treat, and manage neurological disorders – but in the past decade, these leaps have accelerated exponentially. At LVIS Corp, we’re driven by a passion for innovation and solving complex neurological challenges. Our team is in the midst of redefining the landscape of diagnosis ... Read more
LVIS Corporation Introduces NeuroMatch® at 2024 American Clinical Neurophysiology Society Meeting
LVIS Corporation, a leading innovator in healthcare technology, is pleased to announce its participation in the upcoming 2024 American Clinical Neurophysiology Society (ACNS) Meeting in Orlando, Florida, from February 29 to March 2, 2024.
